Table 1. Summary of previously reported cases of superficial tumors treated with radiotherapy using a hydrogen peroxide bolus.
fr., fraction; EQD2α/β10, the equivalent dose in 2 Gy per fraction with α/β of 10; M, months; Refs, references; NA, not assessed; PR, partial response; CR, complete response. Adverse effect was assessed by the Common Terminology Criteria for Adverse Events 4.0, where G indicates grade. *Japanese book (ISBN: 978-4-86705-804-6).
| Cancer type | n | Radiation | Dose/fr. | EQD2α/β10 | Follow-up (M) | Outcome | Adverse effect | Refs |
| Breast cancer | 1 | Electrons | 48 Gy/12 fr. | 56 Gy | 3 | PR | Dermatitis (G1) | [6] |
| Melanoma | 1 | Electrons | 48 Gy/12 fr. | 56 Gy | 12 | CR | Dermatitis (G1) | [6] |
| Malignant fibrous histiocytoma | 1 | Electrons | 48 Gy/12 fr. | 56 Gy | 3 | PR | Dermatitis (G1) | [6] |
| Skin squamous cell carcinoma | 1 | Electrons | 48 Gy/12 fr. | 56 Gy | 1 | PR | Dermatitis (G1) | [6] |
| Extramammary Paget's disease | 1 | Electrons | 48 Gy/12 fr. | 56 Gy | 12 | CR | Dermatitis (G1) | [6] |
| Angiosarcoma | 2 | Electrons | 52.5 Gy/21 fr. | 54.7 Gy | NA | NA | Dermatitis (G2, 50%) | * |
| Malignant trichilemmoma | 1 | X-rays | 54 Gy/27 fr. | 54 Gy | 3 | CR | NA | * |
| Penile cancer | 1 | X-rays | 64 Gy/32 fr. | 64 Gy | NA | CR | Dermatitis (G3) | * |
| Breast cancer | 1 | X-rays | 51 Gy/17 fr. | 55.2 Gy | 4 | CR | Dermatitis (G1) | Present case |